[Benefit and risks of prolonged continued anticoagulant treatment in patients who have experienced a transmural heart infarct].
D000367:Age Factors; D000368:Aged; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002543:Cerebral Hemorrhage / Q000139:chemically induced; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D008875:Middle Aged; D009203:Myocardial Infarction / Q000517:prevention & control*; D011446:Prospective Studies; D011897:Random Allocation; D012008:Recurrence; D012306:Risk; D013997:Time Factors
D000925:Anticoagulants
Het nut en de risico's van langdurig voortgezette antistollingsbehandeling bij patiënten die een transmuraal hartinfarct hebben doorgemaakt.